Call for Abstracts

Abstract submission has ended. Thank you very much for your cooperation!

Instructions for Authors for Preparation and Submission of the Abstracts for
the 5^th Biennial Conference of the International Society for Bipolar Disorders to be Held in Istanbul, Turkey,
March 14-17, 2012

These instructions explain the process for preparing and submitting the abstract for the 5th Biennial Conference of the International Society for Bipolar Disorders.

Topics of Interest:
Pharmacological treatment of bipolar disorder,
Diagnostic issues,
Biomarkers/Endophenotypes,
Imaging,
Cognitive functioning/Neural circuits,
Psychosocial interventions,
Functionality,
Reproductive cycle,
Psychiatric and medical comorbidities,
Stigmatization,
Neurobiology/ molecular and cellular basis of bipolar disorder,
Genetics,
Childhood bipolarity,
Geriatric bipolarity.

Deadline: The deadline for abstract submission is October 17, 2011. Abstracts received after the deadline are not guaranteed to be included in the abstract book or CD of abstracts.

Method of Submission: The Abstract may only be submitted online, using the Web site at http://www.isbd2012.org. Abstracts sent by fax or email will not be accepted.

Confirmation of Submission: After you submit your abstract, you will receive a confirmation email containing the title of your abstract, your abstract number and the submission date. Please remember to save your abstract number as it will be used for corrections, scheduling and notification.

Notification of Acceptance: Authors will receive confirmation of accepted abstracts by November 30, 2011. Following notification of acceptance, the first author must register for the conference by December 8, 2011; abstracts can only be presented on receipt of the registration fee. Authors may register on the Conference website at www.isbd2012.org. Please note the early registration deadline is December 22, 2011. In case of a bank transfer, please ensure to send the receipt to the Congress Secretariat.

Presentation Format: Authors can send abstracts for oral or poster presentation but the scientific committee retains the final decision to choose the presentation format. Accepted abstracts will be published in the journal, "Bipolar Disorders", Abstract Book for 5^th Biennial Conference of the International Society for Bipolar Disorders and on the Congress CD.

Abstract Format Requirements

Please refer the guidelines below and the sample abstract provided.
Failure to meet all requirements below may result in return of your abstract for corrections and delay your submission.

Paper Size and Margins: Please set your word-processing software for standard US letter-size paper (8.5 in × 11 in, or 21.6 cm × 27.9 cm). Margins should be set to 1 in (2.54 cm) on all four sides.

Language and Length: Abstracts must be submitted in English and cannot be more than 350 words (title included).

Title: Font must be 12 pt. Arial, bold, left aligned. Make the title brief, clearly indicating the nature of the investigation. Capitalize only the first word of the Title. Use a carriage return after the title, but do not leave a blank line.

Authors: Font must be 10 pt. Arial, bold, left and right justified. Authors list should appear immediately under the title. Authors should be listed by last name and initials with no periods (i.e. ME Thase, DJ Kupfer, S Gershon). The name of the author expected to present the paper should be underlined (most often it will be the first author). The first author** named will normally be the first point of contact in communication with the ISBD Secretariat. Do not include degrees. Use a carriage return after the author list, but do not leave a blank line.

Affiliations: Font must be 10 pt. Arial, italicized, left and right justified. Affiliations should appear immediately under the author list; if the authors are affiliated with different institutions, the affiliations should be clearly marked with superscripts (using only lowercase letters) indicating to which author they refer. Affiliations should be separated by comas, and should include the Department, Institution, City, State for US address only, and Country. Leave a blank line after Affiliations.

Body text: Font must be 10 pt. Arial, left and right justified, single spaced with a carriage return between paragraphs. Do not leave a blank line between paragraphs. Sub headings (i.e. Background, Methods, Results, Discussion, and Conclusion and Keywords) must be bold. A Maximum of 5 keywords will be accepted. Do not include any figures or tables in your abstract.

** The First author will need to provide a full mailing address (including country), email and phone on the abstract submission form as they will be the contact.

Sample Abstract

Abstract below is several years old

Enhanced Clinical Intervention (ECI): A manualized disease management strategy for bipolar disorder. First results from the Bipolar Disorder Center for Pennsylvanians study
E Frank^a, A Fagiolini^a, S Turkin^b, PR Houck^a, A Fasiczka^a, W Thompson^a, VJ Grochocinski^a, I Soreca^a, H Cheng^a, DJ Kupfer^a^aUniversity of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA, ^bDubois Regional Medical Center, Dubois, PA, USA

Introduction: The Bipolar Disorder Center for Pennsylvanians (BDCP) study is a multi-center randomized controlled study involving subjects with bipolar disorders of age 12 to 84, conducted between 2003 and 2007. The purpose of BDCP is to investigate ways to reduce health disparities related to bipolar disorder, with special attention to those populations, such as African American patients, who are at higher risk of not being appropriately diagnosed or treated.
Methods: The BDCP study tested the effectiveness of a new manualized disease management intervention for Bipolar Disorder: the Enhanced Clinical Intervention (ECI). ECI is a manualized system of education and clinical management and consists of consists of 10 basic components. 1) education about the mood disorder itself, 2) education about medications used to treat the disorder, 3) education about basic sleep and social rhythm hygiene and 4) education regarding the use of rescue medication. 5) careful review of symptoms, 6) a careful review of side effects, 7) medical and behavioral management of side effects, 8) discussion of early-warning signs of impending episodes, 9) 24‑hour on-call service and 10) non specific support. This paper reports on the change in Clinical Global Impression-Bipolar Disorder score that we observed in the first 348 subjects who completed one year of treatment as part of the BDCP study after being randomized to either pharmacotherapy alone or pharmacotherapy plus ECI.
Results: An ordinal logistic model using cumulative logits modeling CGI score after 1 year of ECI or non-ECI treatment, covarying for baseline CGI score, found a significant race by treatment interaction (p=.027), with the non-Caucasian patients showing a particularly favorable response to ECI, and found a significant age by treatment interaction (p=.0084), with the adult patients showing the most benefit from ECI. Of note, 90% of the study non-Caucasian patients were African American (73%) or biracial (17%).
Discussion: Enhanced Clinical Intervention, delivered on a background of standardized pharmacotherapy, appears to be particularly beneficial to African American patients and to the adult population.
Key Words: Bipolar, Psychotherapy, Enhanced Clinical Intervention, Psychosocial